We are live on ! Find out more
CCM

Compton Capital Management Portfolio holdings

AUM $4.32M Turnover 83.33%
1-Year Est. Return 27.38%
This Fund
S&P 500
This Quarter Est. Return
+1.14%
1 Year Est. Return
+27.38%
3 Year Est. Return
+75.57%
5 Year Est. Return
+123.58%
10 Year Est. Return
+303.58%
AUM
$182M
AUM Growth
+$2.29M
Cap. Flow
-$36.9K
Cap. Flow %
-0.02%
Top 10 Hldgs %
34.55%
Holding
141
New
3
Increased
29
Reduced
63
Closed
1
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.6 years

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$254K
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$218K
3
AAPL icon
Apple
AAPL
+$202K
4
SLB icon
SLB Ltd
SLB
+$81.2K
5
FDX icon
FedEx
FDX
+$74K

Sector Composition

Rank Sector Weight
1 Healthcare 20.79%
2 Technology 17.57%
3 Financials 14.84%
4 Industrials 11.19%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XLU icon
126
State Street Utilities Select Sector SPDR ETF
XLU
$24.2B
$243K 0.13%
11,700
-400
-3% -$8.76K
2013 Q2
8 quarters
TWX
127
DELISTED
Time Warner Inc
TWX
$237K 0.13%
2,707
– –
2014 Q4
2 quarters
A icon
128
Agilent Technologies
A
$49.7B
$235K 0.13%
6,081
– –
2014 Q2
4 quarters
DUK icon
129
Duke Energy
DUK
$93.3B
$235K 0.13%
3,330
+100
+3% +$7.56K
2013 Q2
8 quarters
ROP icon
130
Roper Technologies
ROP
$37.9B
$233K 0.13%
1,350
– –
2014 Q4
2 quarters
APD icon
131
Air Products & Chemicals
APD
$65.8B
$232K 0.13%
1,829
– –
2014 Q1
5 quarters
BCS.PRD.CL icon
132
DELISTED
Barclays Bank Plc
BCS.PRD.CL
$226K 0.12%
8,700
– –
2013 Q2
8 quarters
TEVA icon
133
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
$222K 0.12%
3,765
– –
2014 Q4
2 quarters
GSK icon
134
GSK
GSK
$98.6B
$216K 0.12%
4,155
– –
2013 Q2
8 quarters
BCS.PRC icon
135
DELISTED
BARCLAYS BK PLC SPONSORED ADS SER 4 PREF SHS (UK)
BCS.PRC
$212K 0.12%
8,199
– –
2013 Q2
8 quarters
MON
136
DELISTED
Monsanto Co
MON
$208K 0.11%
1,950
– –
2013 Q4
6 quarters
OXY icon
137
Occidental Petroleum
OXY
$60.6B
$204K 0.11%
+2,629
New +$205K
2015 Q2
0 quarters
SCU
138
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$126K 0.07%
+1,030
New +$131K
2015 Q2
0 quarters
QMCO icon
139
Quantum Corp
QMCO
$814M
$34K 0.02%
125
– –
2013 Q2
8 quarters
RXII
140
DELISTED
GALENA BIOPHARMA INC COM
RXII
$26K 0.01%
15,000
– –
2014 Q2
4 quarters
CYH icon
141
Community Health Systems
CYH
$420M
– –
-5,869
Closed -$254K –

Similar funds

Compton Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Compton Capital Management held 141 positions worth $182M, up 1.3% from $180M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 2.8%. Compton Capital Management opened 3 new positions and exited 1, leaving the 141-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Compton Capital Management's largest Q2 2015 buy was iShares Biotechnology ETF: 4,614 shares worth $567K.
  • Compton Capital Management added most to Merck in Q2 2015, an estimated $113K increase.
  • Compton Capital Management's biggest Q2 2015 reduction was Alphabet (Google) Class C, cutting an estimated $218K.
  • Compton Capital Management fully exited Community Health Systems in Q2 2015, selling an estimated $254K.
  • Compton Capital Management's ten largest holdings make up 35% of its $182M portfolio in Q2 2015.
  • Compton Capital Management opened 3 new positions and closed 1 in Q2 2015.
  • Compton Capital Management's portfolio value rose 1.3% quarter-over-quarter to $182M.

Based on Compton Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.